These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 8739603
1. Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication. Diabata M, Enzinger EM, Monroe JE, Kilkuskie RE, Field AK, Mulder C. Antiviral Res; 1996 Mar; 29(2-3):243-60. PubMed ID: 8739603 [Abstract] [Full Text] [Related]
2. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. Le Roux F, Sergeant A, Corbo L. J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788 [Abstract] [Full Text] [Related]
3. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication. Lyons DE, Yu KP, Vander Heiden JA, Heston L, Dittmer DP, El-Guindy A, Miller G. J Virol; 2018 Oct 01; 92(19):. PubMed ID: 30021895 [Abstract] [Full Text] [Related]
4. Demethylation of the Epstein-barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report. Falk KI, Ernberg I. Arch Virol; 1999 Oct 01; 144(11):2219-27. PubMed ID: 10603176 [Abstract] [Full Text] [Related]
5. Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification. Yao GQ, Grill S, Egan W, Cheng YC. Antimicrob Agents Chemother; 1993 Jul 01; 37(7):1420-5. PubMed ID: 8395789 [Abstract] [Full Text] [Related]
6. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication. Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S. J Virol; 1996 Aug 01; 70(8):5131-42. PubMed ID: 8764021 [Abstract] [Full Text] [Related]
13. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. Fahmi H, Cochet C, Hmama Z, Opolon P, Joab I. J Virol; 2000 Jul 15; 74(13):5810-8. PubMed ID: 10846060 [Abstract] [Full Text] [Related]
14. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression. Yang EV, Webster Marketon JI, Chen M, Lo KW, Kim SJ, Glaser R. Brain Behav Immun; 2010 Oct 15; 24(7):1089-96. PubMed ID: 20466055 [Abstract] [Full Text] [Related]
15. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. Shimizu N, Takada K. J Virol; 1993 Jun 15; 67(6):3240-5. PubMed ID: 8388498 [Abstract] [Full Text] [Related]
19. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1. Cho MS, Tran VM. Virology; 1993 Jun 15; 194(2):838-42. PubMed ID: 8389085 [Abstract] [Full Text] [Related]
20. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin. Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Wu TC, Gao M, Cheng AL. Anticancer Res; 2002 Jun 15; 22(6C):4065-71. PubMed ID: 12553034 [Abstract] [Full Text] [Related] Page: [Next] [New Search]